Celyad SA Gains 137.8%

Tue, Jan 17, 2023 at 06:57 PM
Celyad SA Gains 137.8%

Celyad SA (CYAD:NASDAQ) shot up at $1.9, a gain of 137.8%. On Tue, Jan 17, 2023, CYAD:NASDAQ hit a New 2-Week High of $1.9. The stock appeared on our News Catalysts scanner on Wed, Dec 21, 2022 at 01:10 PM in the 'INVESTOR UPDATE' category. From Tue, Jan 03, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days

The stock spiked on Tue, Jan 17, 2023 at $2.5 with a volume of 65M+.

About Celyad SA (CYAD:NASDAQ)

Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.